Q3 2020 · —
Revenue$52.00K$52.00K no prior Q3 2019 on file+23.8% vs Q2 2020
Net Income-$7.26M-$7.26M no prior Q3 2019 on fileN/M vs Q2 2020
EPS Diluted-$0.43-$0.43 no prior Q3 2019 on fileN/M vs Q2 2020
Operating Income-$7,711,000—
Operating Cash Flowderived-$7,235,000—
Free Cash Flowderived-$11,537,000—
Margins · derived
Operating margin-14828.8%
Net margin-13965.4%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q3 2019 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR